This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

17 Feb 2012

Sigma-Aldrich Completes Acquisition of BioReliance

The acquisition will leverage SAFC’s industrial media presence and BioReliance’s biological testing services.

Sigma-Aldrich Corporation, a leading Life Science and High Technology company, has completed its acquisition of BioReliance Holdings, Inc., a leading provider of global biopharmaceutical testing services, from Avista Capital Partners for $350 million in cash, subject to normal post-closing adjustments.


BioReliance will become part of SAFC, the custom manufacturing and services business unit of Sigma-Aldrich.


BioReliance provides critical services that include biologic, specialized toxicology and animal health testing to pharmaceutical, biopharmaceutical, diagnostics, and other life science customers worldwide. As a leading provider of biological safety testing, its service offering helps facilitate the development, manufacturing and commercialization of

Related News